  Black cumin (Nigella sativa) is a spice having medicinal properties with
pungent and bitter odour. It is used since thousands of years to treat various
ailments, including cancer mainly in South Asia and Middle Eastern regions.
Substantial evidence in multiple research studies emphasizes about the
therapeutic importance of bioactive principles of N. sativa in cancer
bioassays; however, the exact mechanism of their anti-tumour action is still to
be fully comprehended. The current study makes an attempt in this direction by
exploiting the advancements in the Insilico reverse screening technology. In
this study, three different Insilico Reverse Screening approaches have been
employed for identifying the putative molecular targets of the bioactive
principles in Black cumin (thymoquinone, alpha-hederin, dithymoquinone and
thymohydroquinone) relevant to its anti-tumour functionality. The identified
set of putative targets is further compared with the existing set of
experimentally validated targets, so as to estimate the performance of insilico
platforms. Subsequently, molecular docking simulations studies were performed
to elucidate the molecular interactions between the bioactive compounds & their
respective identified targets. The molecular interactions of one such target
identified i.e. VEGF2 along with thymoquinone depicted one H-bond formed at the
catalytic site. The molecular targets identified in this study need further
confirmatory tests on cancer bioassays, in order to justify the research
findings from Insilico platforms. This study has brought to light the
effectiveness of usage of Insilico Reverse Screening protocols to characterise
the un-identified target-ome of poly pharmacological bioactive agents in
spices.
